Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body – identifying ways to block its escapeImage of human melanoma tissue, with melanoma cells in green and purple ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned.

ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS moneyA new AI test can pick out which men with high-risk prostate cancer that has not spread will require ...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer.

A pioneering research study which will allow brain cancer patients to access drugs that are precisely targeted to their disease and swap to different treatments if needed, has launched in the UK. The ...

ICR welcomes plans for £1 billion development to create world-leading cancer research district in SuttonThe Institute of Cancer Research has welcomed new plans to deliver around one million square ...

Scientists from the ICR have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for ...

Cell biologists have made a significant advance, uncovering the key role of an enzyme in determining the physical structure and behaviour of cancer cells, including how they spread.

A new study suggests that silencing CXCL12, a gene involved in tissue scarring and repair, could help reduce the formation of scar tissue that can caused by radiotherapy. Ultimately, the researchers ...